Contreras-Galindo et al., 2008 - Google Patents
Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancerContreras-Galindo et al., 2008
View HTML- Document ID
- 3929733638551603709
- Author
- Contreras-Galindo R
- Kaplan M
- Leissner P
- Verjat T
- Ferlenghi I
- Bagnoli F
- Giusti F
- Dosik M
- Hayes D
- Gitlin S
- Markovitz D
- Publication year
- Publication venue
- Journal of virology
External Links
Snippet
Actively replicating endogenous retroviruses entered the human genome millions of years ago and became a stable part of the inherited genetic material. They subsequently acquired multiple mutations, leading to the assumption that these viruses no longer replicate …
- 241000192019 Human endogenous retrovirus K 0 title abstract description 135
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—AIDS or HTLV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Contreras-Galindo et al. | Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer | |
| Kirchhoff et al. | Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease | |
| Hung et al. | Importance of ribosomal frameshifting for human immunodeficiency virus type 1 particle assembly and replication | |
| Sharkey et al. | Episomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failure | |
| Sanyal et al. | Novel assay reveals a large, inducible, replication-competent HIV-1 reservoir in resting CD4+ T cells | |
| Allander et al. | Identification of a third human polyomavirus | |
| Demontis et al. | HTLV‐1 viral RNA is detected rarely in plasma of HTLV‐1 infected subjects | |
| Gurer et al. | Specific incorporation of heat shock protein 70 family members into primate lentiviral virions | |
| Resch et al. | Nelfinavir-resistant, amprenavir-hypersusceptible strains of human immunodeficiency virus type 1 carrying an N88S mutation in protease have reduced infectivity, reduced replication capacity, and reduced fitness and process the Gag polyprotein precursor aberrantly | |
| Marozsan et al. | Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates | |
| Madani et al. | An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein | |
| Tang et al. | Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells | |
| Ni et al. | Cellular proteins required for adeno-associated virus DNA replication in the absence of adenovirus coinfection | |
| Roa et al. | RING domain mutations uncouple TRIM5α restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating | |
| Thorstensson et al. | Strategies for diagnosis of HTLV‐I and‐II | |
| Shin et al. | Absence of XMRV retrovirus and other murine leukemia virus-related viruses in patients with chronic fatigue syndrome | |
| Yang et al. | Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers | |
| Agopian et al. | A hydrophobic binding surface on the human immunodeficiency virus type 1 Nef core is critical for association with p21-activated kinase 2 | |
| Fun et al. | A highly reproducible quantitative viral outgrowth assay for the measurement of the replication-competent latent HIV-1 reservoir | |
| Zhou et al. | Human immunodeficiency virus type 1 resistance to the small molecule maturation inhibitor 3-O-(3′, 3′-dimethylsuccinyl)-betulinic acid is conferred by a variety of single amino acid substitutions at the CA-SP1 cleavage site in Gag | |
| Tang et al. | Human immunodeficiency virus type 1 N-terminal capsid mutants containing cores with abnormally high levels of capsid protein and virtually no reverse transcriptase | |
| van Domselaar et al. | HIV-1 subtype C with PYxE insertion has enhanced binding of Gag-p6 to host cell protein ALIX and increased replication fitness | |
| Robles et al. | Analysis of viruses present in urine from patients with interstitial cystitis | |
| Ji et al. | Development and validation of a duplex real-time PCR for the rapid detection and quantitation of HTLV-1 | |
| Goto et al. | Association of plasma viral RNA load with prognosis in cats naturally infected with feline immunodeficiency virus |